Biznews8d
🔒 Novo’s insulin pen phase-out sparks CompCom probe as diabetes remains a silent killer among SA women
South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.
South African watchdog probes Novo Nordisk and Sanofi over insulin
South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
Ask Your Pharmacist: Needle-free insulin pen gives diabetics another option
Q: I saw an advertisement in a magazine for a needle-free insulin pen. Can you tell me more about how this works and is it ...
Insulin Pens Market Report 2024: Segments, Share, Regulatory, Reimbursement and Forecasts to 2036 Featuring Novo Nordisk AS, Eli Lilly and Co, Sanofi
The "Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added to ResearchAndMarkets.com's offering.The report is built to visualize ...
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin ...
South African Competition Commission probes Novo Nordisk and Sanofi over insulin pen market
South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over their insulin pen market practices, amid growing concerns about ...
Embecta: Weak Outlook But Mouth-Watering Valuation Skew Risk-Reward In Favour
Embecta's compelling ~44% free cash flow yield offers a strong risk-reward despite headwinds from new insulin technologies ...
News2410d
SA watchdog to probe global giants over insulin pens
Novo Nordisk and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market. South Africa’s Competition Commission said ...